SPP1 and cancer: Treating monocytes with OPN-rich conditioned media from cancer cells leads to an increase in M2 macrophages, and a co-implanted xenograft of OPN-expressing tumor cells and monocytes leads to enhancement of tumor growth and poor survival in gastric cancer mouse models [135].